YY1 and pediatric osteosarcoma: On the other hand, the expression of YY1 was decreased in PDAC, NPC, pediatric osteosarcoma, etc., and negatively correlated with its clinical progression and a poor prognosis, suggesting that the low YY1 expression predict poor prognosis of these tumors.